1-1 of 1
Heike Pahl, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment with Pegylated Interferon α (PegIntron) for High-Risk Essential Thrombocythemia: Results of a Phase II Study.

Christian Langer, MD, Eva Lengfelder, MD, Jurgen Thiele, MD, Hans M. Kvasnika, MD, Heike Pahl, PhD, Axel Matzdorff, MD, Barbara Stade, Stefanie Schauer, Heinz Gisslinger, MD, Hartmut Dohner, MD, Martin Griesshammer, MD
Journal: Blood
Blood (2004) 104 (11): 1522.
https://doi.org/10.1182/blood.V104.11.1522.1522
Published: 2004